Community-acquired Staphylococcus aureus infections: Increasing virulence and emerging methicillin resistance in the new millennium.
Stevens
Dennis L
DL
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001427:Bacterial Toxins; D021821:Communicable Diseases, Emerging / Q000276:immunology / Q000382:microbiology; D017714:Community-Acquired Infections / Q000188:drug therapy / Q000378:metabolism / Q000382:microbiology; D003428:Cross Infection / Q000382:microbiology; D004768:Enterotoxins / Q000235:genetics / Q000276:immunology; D006801:Humans; D007769:Lactams; D016106:Methicillin Resistance / Q000235:genetics / Q000276:immunology; D013203:Staphylococcal Infections / Q000188:drug therapy* / Q000378:metabolism / Q000382:microbiology; D013211:Staphylococcus aureus / Q000187:drug effects / Q000235:genetics / Q000472:pathogenicity*; D018089:Superantigens; D014774:Virulence
D000900:Anti-Bacterial Agents; D001427:Bacterial Toxins; D004768:Enterotoxins; D007769:Lactams; D018089:Superantigens; C030107:enterotoxin F, Staphylococcal